Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
letter
. 2020 May 13;30(9):5217–5219. doi: 10.1007/s00330-020-06918-2

Mobile X-rays are highly valuable for critically ill COVID patients

Gang Wu 1, Xiaoming Li 1,
PMCID: PMC7220577  PMID: 32405750

Dear Editor,

The diagnostic value of CT for SARS-CoV-2 infection has been widely reported [1, 2]. However, performing CT is very difficult in critically ill patients in ICU, whereas mobile X-rays serve as an alternative. From Feb. 20 to Mar. 20, 542 mobile chest X-rays were performed in 229 COVID patients who were under assisted ventilation. Table 1 summarizes the main characteristics of the cohort.

Table 1.

The main characteristics of 229 patients with SARS-CoV-2 pneumonia with mobile X-rays

Age and sex
  Mean age (standard deviation) (years)  59.3 (13.7)
  Age range (years)  24~95
  Male:female 147:82
Outcome as of Mar. 30
  Non-survivor  95 (41%)
  Survivor Discharge  58 (25%)
Invasive ventilation  35 (15%)
Noninvasive ventilation  27 (12%)
High-flow oxygen inhalation  14 (6%)
Number of X-rays per patient
  1  84 (37%)
  2  58 (25%)
  3  46 (20%)
  4  25 (11%)
  5  11 (5%)
  ≥ 6   5 (2%)
Main findings
  Pneumothorax  16 (7%)
  Pleural effusion  53 (23%)
  Subcutaneous emphysema   4 (2%)
  Hiatal hernia of esophagus   3 (1%)
  Intrapulmonary cavity   2 (1%)
Follow-up X-ray (n = 313)
  Compared to previous X-ray Progress 119 (38%)
No changes  57 (18%)
Improvement 137 (44%)

SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2

Among the 229, a significant underlying disease existed in 165 (72%): hypertension in 31%, chronic heart disease in 13%, chronic pulmonary disease in 12%, and malignancy in 11%. As of Mar. 30, 95 (41%) of 229 patients had died, and 134 (59%) survived. Among them, 58 were discharged and 76 still in hospital.

Table 1 shows the number of X-rays performed per patient. There were 229 initial examination and 313 were follow-ups. The image quality was diagnostic for all these X-rays.

Extensive pneumonia was seen on the initial X-rays in all patients. Other findings were pneumothorax (7%) and pleural effusion (23%). Subcutaneous emphysema, hiatal hernia, and intrapulmonary cavity were rare findings (Table 1). All patients with pneumothorax died. Compared to previous X-rays, increase of pneumonia was seen in 119 (38%) of 313 follow-up X-rays, while no changes were seen in 57 (18%), and improvement in 137 (44%).

Among non-survivors (n = 95), 61 patients did not have follow-up X-rays and died 1~4 days after the initial examination; 34 patients had 55 follow-up X-rays. Pneumonia progress was seen in 53 (96%) out of 55 follow-up X-rays when compared to previous radiograph (Fig. 1).

Fig. 1.

Fig. 1

A 57-year-old female with laboratory-confirmed SARS-CoV-2 pneumonia had dyspnea one week after onset of symptoms of fever and diarrhea. Under high-flow oxygen inhalation, her pulse oxygen saturation (SPO2) was only 60%; thus, invasive ventilation was used with fraction of inspired oxygen 50–70% to maintain SPO2 around 95%. On Feb. 21, she underwent the first mobile X-ray, which indicated extensive pneumonia. Compared with initial X-ray, significant progress could be seen in the follow-up X-ray on Feb. 24, which was a typical “white lung.” A new intrapulmonary cavity was revealed by the second X-ray, and was significantly larger in the third X-ray on Mar. 1. The patient died of respiratory failure four days after the last X-ray

Among survivors (n = 134), 111 patients had 258 follow-up X-rays. Pneumonia progress was seen in 66/258 radiographs (26%) of follow-up X-rays in 37 survivors; however, improvement was seen later.

We found mobile X-rays provided adequate image quality for diagnosing pneumonia, at least in this population of severely ill patients. Although obviously less informative than CT, X-rays can nevertheless detect serious complications like pneumothorax or lung cavitation, and estimate the evolution of pneumonia. Therefore, it is a simple but reliable alternative in critically ill SARS-CoV-2 patients who could not undergo chest CT.

Funding information

This work received financial support from the National Natural Science of Foundation of China, No. 81801663, 31630025, and 81571643.

Compliance with ethical standards

Guarantor

The scientific guarantor of this publication is Wenzhen Zhu.

Conflict of interest

The authors declare that they have no conflict of interest.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Not applicable.

Ethical approval

Institutional Review Board approval was not required because this publication is a Letter to the Editor.

Methodology

  • Not applicable

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Ye Z, Zhang Y, Wang Y, Huang Z, Song B (2020) Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. 10.1007/s00330-020-06801-0 [DOI] [PMC free article] [PubMed]
  • 2.Kim H (2020) Outbreak of novel coronavirus (COVID-19): what is the role of radiologists? Eur Radiol. 10.1007/s00330-020-06748-2 [DOI] [PMC free article] [PubMed]

Articles from European Radiology are provided here courtesy of Nature Publishing Group

RESOURCES